Mercer Global Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Mercer Global Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,910	Closed	-$536K	–	1221
2019 Q3	$536K	Hold	7,910	–	–	0.01%	670
2019 Q2	$460K	Buy	7,910 +98	+1%	+$5.81K	0.01%	715
2019 Q1	$547K	Buy	+7,812	New	+$579K	0.02%	596

Mercer Global Advisors's GHDX Position: Q4 2019 in Review

Mercer Global Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 7,910 shares — an estimated $536K sold.

Mercer Global Advisors first reported a position in GHDX in Q1 2019 and held it in 3 quarters. The position peaked at $547K in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Mercer Global Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Mercer Global Advisors sold 7,910 Genomic Health, Inc. shares in Q4 2019, an estimated $536K.
Mercer Global Advisors first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 3 quarters.
Mercer Global Advisors's Genomic Health, Inc. position peaked at $547K in Q1 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Mercer Global Advisors's 13F filing for Q4 2019, filed 13 Feb 2020.